US Stock MarketDetailed Quotes
CHRO Chromocell Therapeutics
- 1.750
- -0.260-12.94%
Close May 17 16:00 ET
- 1.750
- 0.0000.00%
Post 16:00 ET
10.09MMarket Cap-1121P/E (TTM)
2.120High1.640Low49.08KVolume2.017Open2.010Pre Close90.64KTurnover1.21%Turnover RatioLossP/E (Static)5.77MShares6.00052wk High8.93P/B7.12MFloat Cap1.21052wk Low--Dividend TTM4.07MShs Float6.000Historical High--Div YieldTTM23.88%Amplitude1.210Historical Low1.846Avg Price1Lot Size
About Chromocell Therapeutics Company
Chromocell Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. Its clinical focus is to selectively target the sodium ion-channel known as \"NaV1.7\", as well as other receptors in the NaV family. The company was founded on March 19, 2021 and is headquartered in Freehold, NJ.
Company Profile
SymbolCHRO
Company NameChromocell Therapeutics
Listing DateFeb 16, 2024
Issue Price6.00
Founded2021
CEOMr. Francis Knuettel, II
MarketAMEX
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4400 Route 9 South,Suite 1000
City07728
ProvinceNew Jersey
CountryUnited States of America
Zip Code08906
Phone1-877-265-8266
Websitehttp://chromocell.com
Company Executives
- Name
- Position
- Salary
- Francis Knuettel, II
- Chief Executive Officer, Chief Financial Officer, Treasurer and Secretary
- 109.99K
- Eric Lang
- Chief Medical Officer
- 168.27K
- Todd C. Davis
- Chairman of the Board
- 748.04K
- Ezra M. Friedberg
- Independent Director
- 374.02K
- Dr. Richard Malamut
- Independent Director
- 374.02K
- Chia-Lin Simmons
- Independent Director
- 336.61K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
